SCHEMBL29430465

SCHEMBL29430465

O=C(N[C@H]1c2ccccc2C[C@H]1O)[C@H](Cc1ccccc1)C[C@H](O)CNS(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ VIPR2 P41587 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15714796 1.00 VIPR2 (1.00) VIPR2
SCHEMBL17038190 1.00 VIPR2 (1.00) VIPR2
SCHEMBL17038202 0.92 VIPR2 (0.85) VIPR2
SCHEMBL15714596 0.92 VIPR2 (0.88) VIPR2
SCHEMBL17038195 0.89 VIPR2 (1.00) VIPR2
SCHEMBL17038186 0.89 VIPR2 (0.88) VIPR2
SCHEMBL17038188 0.89 VIPR2 (0.85) VIPR2
SCHEMBL17038291 0.89 VIPR2 (1.00) VIPR2
SCHEMBL17038294 0.89 VIPR2 (1.00) VIPR2
SCHEMBL17038296 0.89 VIPR2 (1.00) VIPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240392312-A1 HUMANIZED VIPR2 COPY NUMBER VARIANT TRANSGENIC MOUSE MODEL FOR ANTIPSYCHOTIC DRUG AND GENE THERAPY DISCOVERY FOR SCHIZOPHRENIA UNIV LOUISIANA STATE (US) 2024-11-28 — — US claimed
US-20220090124-A1 HUMANIZED VIPR2 COPY NUMBER VARIANT TRANSGENIC MOUSE MODEL FOR ANTIPSYCHOTIC DRUG AND GENE THERAPY DISCOVERY FOR SCHIZOPHRENIA UNIV LOUISIANA STATE (US) 2022-03-24 — — US claimed
US-20240392312-A1 HUMANIZED VIPR2 COPY NUMBER VARIANT TRANSGENIC MOUSE MODEL FOR ANTIPSYCHOTIC DRUG AND GENE THERAPY DISCOVERY FOR SCHIZOPHRENIA UNIV LOUISIANA STATE (US) 2024-11-28 — — US disclosed
US-20220090124-A1 HUMANIZED VIPR2 COPY NUMBER VARIANT TRANSGENIC MOUSE MODEL FOR ANTIPSYCHOTIC DRUG AND GENE THERAPY DISCOVERY FOR SCHIZOPHRENIA UNIV LOUISIANA STATE (US) 2022-03-24 — — US disclosed
Send feedback